rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Raza Bokhari

Chief Executive Officer

Company insider

Files Form 4 as: Chief Executive Officer, Medicus Pharma; Director, Q/C Technologies.

Every Form 4 they filed

In numbers

Trades disclosed
11
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
1
First trade
30 Dec 2015
Last trade
4 Sep 2026
Last filed
8 Sep 2026

Companies traded

Where they are an officer
MDCX Medicus PharmaDirector, Officer · Biotechnology · last 4 Sep 20260 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
QCLS Q/C TechnologiesDirector · Diagnostics & Labs · last 30 Dec 20150 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
4 Sep 2026filed 8 Sep 2026MDCX Medicus PharmaBiotechnologySEC FORM 4 Code A$501K2,941,176 at $0.1705filing
4 Sep 2026filed 8 Sep 2026MDCX Medicus Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—500,000 at $0.00filing
4 Sep 2026filed 8 Sep 2026MDCX Medicus Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—500,000 at $0.00filing
4 Sep 2026filed 8 Sep 2026MDCX Medicus PharmaBiotechnologySEC FORM 4 Code A$500K2,941,176 at $0.17filing
3 Jun 2026filed 4 Jun 2026MDCX Medicus Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—500,000 at $0.00filing
3 Jun 2026filed 4 Jun 2026MDCX Medicus Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—500,000 at $0.00filing
30 Mar 2026filed 1 Apr 2026MDCX Medicus Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—325,000 at $0.00filing
30 Mar 2026filed 1 Apr 2026MDCX Medicus Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—325,000 at $0.00filing
16 Dec 2025filed 18 Dec 2025MDCX Medicus Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—125,000 at $0.00filing
22 Jul 2025filed 24 Jul 2025MDCX Medicus Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—250,000 at $0.00filing
30 Dec 2015filed 31 Dec 2015QCLS Q/C TechnologiesDiagnostics & LabsSEC FORM 4 Code A—32,083 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Carolyn F. BonnerPresident and CFO · President and CFO at Medicus Pharma, filing Form 4 there in the last year
Faisal MehmudChief Medical Officer · Chief Medical Officer at Medicus Pharma, filing Form 4 there in the last year
Andrew Alasdair SmithChief Operating Officer · Chief Operating Officer at Medicus Pharma, filing Form 4 there in the last year
Edward J. BrennanChief Scientific Officer · Chief Scientific Officer at Medicus Pharma, filing Form 4 there in the last year
Larry KaiserDirector · Director at Medicus Pharma, filing Form 4 there in the last year